Literature DB >> 9794703

Permeability characteristics of hemoglobin derivatives across cultured endothelial cell monolayers.

K Nakai1, I Sakuma, T Ohta, J Ando, A Kitabatake, Y Nakazato, T A Takahashi.   

Abstract

To better understand the vascular activity of hemoglobin-based (Hb-based) oxygen carriers, the endothelial permeability characteristics of Hb derivatives having various molecular masses were defined by using monolayers of bovine endothelial cells cultured on microporous membranes. The endothelial permeability of unmodified bovine Hb was almost twice that of bovine serum albumin. Intramolecularly cross-linked human Hb showed slightly but significantly reduced permeability as compared with unmodified bovine Hb. Polyethyleneglycol modification or haptoglobin binding to Hb further reduced the permeability. These properties were intensified in conditions in which the endothelial barrier function was reduced by pretreatment with either interleukin-6 (100 ng/mL, 21 hours) or lipopolysaccharide (1 microg/mL, 10 hours). In contrast, there was little permeability of liposome-encapsulated Hb, and it was almost unaffected by the pretreatments. These data provide the first information that Hb derivatives with smaller molecular masses show larger transendothelial flux. Because Hb is a potent scavenger of endothelium-derived relaxing factor (EDRF), our observations support the idea that smaller Hb-based acellular oxygen carriers are potent vasoconstrictors as a result of abluminal EDRF scavenging.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9794703     DOI: 10.1016/s0022-2143(98)90045-2

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  10 in total

1.  Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapy.

Authors:  Jin Hyen Baek; Felice D'Agnillo; Florence Vallelian; Claudia P Pereira; Matthew C Williams; Yiping Jia; Dominik J Schaer; Paul W Buehler
Journal:  J Clin Invest       Date:  2012-03-26       Impact factor: 14.808

2.  Haem oxygenase shows pro-oxidant activity in microsomal and cellular systems: implications for the release of low-molecular-mass iron.

Authors:  N J Lamb; G J Quinlan; S Mumby; T W Evans; J M Gutteridge
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

3.  Human Hp1-1 and Hp2-2 phenotype-specific haptoglobin therapeutics are both effective in vitro and in guinea pigs to attenuate hemoglobin toxicity.

Authors:  Miriam Lipiski; Jeremy W Deuel; Jin Hyen Baek; Wolfgang R Engelsberger; Paul W Buehler; Dominik J Schaer
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

4.  Effect of a bradykinin-potentiating factor isolated from scorpion venom (Leiurus quinquestriatus) on some blood indices and lipid profile in irradiated rats.

Authors:  Muhammad M A Salman; Ahmed M Kotb; Mohie A M Haridy; Klaus Golka; Seddik Hammad
Journal:  Mol Cell Biochem       Date:  2017-04-08       Impact factor: 3.396

5.  Sequestration of extracellular hemoglobin within a haptoglobin complex decreases its hypertensive and oxidative effects in dogs and guinea pigs.

Authors:  Felicitas S Boretti; Paul W Buehler; Felice D'Agnillo; Katharina Kluge; Tony Glaus; Omer I Butt; Yiping Jia; Jeroen Goede; Claudia P Pereira; Marco Maggiorini; Gabriele Schoedon; Abdu I Alayash; Dominik J Schaer
Journal:  J Clin Invest       Date:  2009-07-20       Impact factor: 14.808

6.  Hemoglobin-based red blood cell substitutes and nitric oxide.

Authors:  Binglan Yu; Kenneth D Bloch; Warren M Zapol
Journal:  Trends Cardiovasc Med       Date:  2009-04       Impact factor: 6.677

Review 7.  Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins.

Authors:  Dominik J Schaer; Paul W Buehler; Abdu I Alayash; John D Belcher; Gregory M Vercellotti
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

Review 8.  Mechanisms of haemolysis-induced kidney injury.

Authors:  Kristof Van Avondt; Erfan Nur; Sacha Zeerleder
Journal:  Nat Rev Nephrol       Date:  2019-08-27       Impact factor: 28.314

Review 9.  Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development.

Authors:  Dominik J Schaer; Francesca Vinchi; Giada Ingoglia; Emanuela Tolosano; Paul W Buehler
Journal:  Front Physiol       Date:  2014-10-28       Impact factor: 4.566

Review 10.  Hemolysis Derived Products Toxicity and Endothelium: Model of the Second Hit.

Authors:  Marie Frimat; Idris Boudhabhay; Lubka T Roumenina
Journal:  Toxins (Basel)       Date:  2019-11-13       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.